DeepHealth vs HeartFlow
DeepHealth and HeartFlow both compete in radiology, but answer different questions. DeepHealth is our pick for global radiology AI portfolio: World's largest after Gleamer acquisition (March 2026). HeartFlow earns the reimbursable CCTA AI slot: Non-invasive CCTA-derived FFR, reimbursable since CPT 75577 (Jan 2026). The right choice depends on whether your priority is global radiology ai portfolio or reimbursable ccta ai.
- Radiology
- 02
- October 20, 2026
DeepHealth
by RadNet / DeepHealth, Inc.
Imaging AI from RadNet's DeepHealth: mammography (Saige-Dx, Saige-Density), breast arterial calcification, prostate, lung, bone and chest X-ray.
- No public price. The homepage shows none.
- FDA 510(k) (multiple) / CE Mark (Mia, 2019, per DeepHealth page)
HeartFlow
by HeartFlow · founded 2007
Coronary CT angiogram analysis: CT-derived fractional flow reserve (FFRct), plaque analysis and a CCTA reading aid.
- No public list price. The 10-K describes revenue as pay-per-use.
- FDA De Novo / FDA 510(k) / CE Mark (FFRct Analysis, 2011)
How DeepHealth and HeartFlow compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified October 20, 2026.
| Spec | DeepHealth | HeartFlow |
|---|---|---|
| Pricing | No public price. The homepage shows none. | No public list price. The 10-K describes revenue as pay-per-use. |
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | — | 2007 |
| HQ | US | US |
| Best for | Best global radiology AI portfolio | Best reimbursable CCTA AI |
Scroll horizontally to see both columns.
When to pick each one
Best global radiology AI portfolio
World's largest after Gleamer acquisition (March 2026).
- RadNet-owned
- CXR, mammography, CT, MRI
- ~$140M ARR projected EOY 2026
- Spans CV + onc + neuro
Best reimbursable CCTA AI
Non-invasive CCTA-derived FFR, reimbursable since CPT 75577 (Jan 2026).
- Most clinical-evidence-backed CCTA AI
- IPO filed 2026
- Eliminates invasive angiography for many patients
Other head-to-heads worth reading
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.